• Gene therapy improves muscle function for children with Spinal Muscular Atrophy

  • Dec 12 2021
  • Length: 4 mins
  • Podcast

Gene therapy improves muscle function for children with Spinal Muscular Atrophy

Listen for free

View show details

  • Summary

  • Children with spinal muscular atrophy(SMA) carry specific gene defects which cause progressive muscle wasting and weakness. The disorder results from a genetic defect that causes a deficiency of the survival motor neuron (SMN) protein in specific nerve cells in the spinal cord. Defective nerve cells are unable to transmit nerve impulses they receive from the brain to the muscles. The result is progressive muscle weakness and a lack of motor development, which also affects the muscles used for breathing. This condition usually results in early death when left untreated. 
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Gene therapy improves muscle function for children with Spinal Muscular Atrophy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available